OSPREY THERAPEUTICS
Ionis Pharmaceuticals, Inc.
Mark For: OSPREY THERAPEUTICS™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87725257 |
| Mark Literal Elements | OSPREY THERAPEUTICS |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2020-12-30 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Karen K. Won |
| Attorney Docket Number | 097721-20084 |
| Law Office Assigned | M60 |
| Employee Name | YARD, JOHN S |
Timeline
| 2017-12-18 | Application Filed |
| 2018-05-15 | Published |
| 2018-05-15 | Published for Opposition |
| 2018-07-10 | Location: INTENT TO USE SECTION |
| 2019-01-04 | Status: Live/Pending |
| 2019-01-08 | Transaction Date |
| 2020-12-30 | Location: INTENT TO USE SECTION |
| 2020-12-30 | Status: A fifth request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Ionis Pharmaceuticals, Inc. |
| Address | 2855 Gazelle Court Carlsbad, CALIFORNIA UNITED STATES 92010 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
Drawing
TEAS RF New ApplicationAttorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; injectable drugs for reducing production of transthyretin; antisense drugs
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; injectable drugs for reducing production of transthyretin; antisense drugs |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-12-31 | |
| EXTENSION 5 GRANTED | 2020-12-30 | 74055 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-12-30 | 74055 |
| TEAS EXTENSION RECEIVED | 2020-12-11 | |
| EXTENSION 5 FILED | 2020-12-11 | 74055 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-07-02 | |
| TEAS EXTENSION RECEIVED | 2020-06-30 | |
| EXTENSION 4 GRANTED | 2020-06-30 | 98765 |
| EXTENSION 4 FILED | 2020-06-30 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-01-07 | |
| TEAS EXTENSION RECEIVED | 2020-01-03 | |
| EXTENSION 3 GRANTED | 2020-01-03 | 98765 |
| EXTENSION 3 FILED | 2020-01-03 | 98765 |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-10-11 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-10-11 | |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-07-10 | |
| TEAS EXTENSION RECEIVED | 2019-07-08 | |
| EXTENSION 2 GRANTED | 2019-07-08 | 98765 |
| EXTENSION 2 FILED | 2019-07-08 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-01-08 | |
| TEAS EXTENSION RECEIVED | 2019-01-04 | |
| EXTENSION 1 GRANTED | 2019-01-04 | 98765 |
| EXTENSION 1 FILED | 2019-01-04 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-07-10 | |
| PUBLISHED FOR OPPOSITION | 2018-05-15 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-05-15 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-04-25 | |
| ASSIGNED TO LIE | 2018-04-04 | 70138 |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-03-30 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2018-03-30 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2018-03-30 | 73713 |
| EXAMINER'S AMENDMENT ENTERED | 2018-03-30 | 88888 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-03-30 | |
| ASSIGNED TO EXAMINER | 2018-03-27 | 73713 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-01-04 | |
| NEW APPLICATION ENTERED IN TRAM | 2017-12-21 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OSPREY THERAPEUTICS 87725262 not registered Live/Pending |
Ionis Pharmaceuticals, Inc. 2017-12-18 |
 OSPREY THERAPEUTICS 87725257 not registered Live/Pending |
Ionis Pharmaceuticals, Inc. 2017-12-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 